J Clin Endocrinol Metab (2006) 91(9):340410
Many patients were not informed by Novo Nordisk or their doctors that blindness caused by NAION was a potential complication
Read more: #PatientSafety #ObesityCare #GLP1 #Tirzepatide #Mounjaro #Wegovy #Pharmacogenomics #MHRA #HSCInnovationObservatory UK deaths linked to GLP-1 drugs: MHRA confirms 82 deaths 82 UK deaths linked to GLP1 drugs (Mounjaro, Wegovy, Ozempic), MHRA confirms
Conclusion As ever in healthcare there is no magic bullet, no cure-all pill but instead the solution is teamwork a network of policy makers, investors, medications, technology, education and behavioural support
### GIP Activation GIP (glucose-dependent insulinotropic polypeptide) amplifies the GLP-1 effect
Kinases as drug targets in the treatment of bipolar disorder